Chondrogenic differentiation potential of osteoarthritic chondrocytes and their possible use in matrix-associated autologous chondrocyte transplantation

被引:99
|
作者
Dehne, Tilo [1 ,2 ]
Karlsson, Camilla [3 ]
Ringe, Jochen [1 ,2 ]
Sittinger, Michael [1 ,2 ]
Lindahl, Anders [3 ]
机构
[1] Charite, Tissue Engn Lab, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany
[2] Charite, Dept Rheumatol & Clin Immunol, Berlin Brandenburg Ctr Regenerat Therapies, D-10117 Berlin, Germany
[3] Sahlgrens Univ Hosp, Dept Clin Chem & Transfus Med, Inst Lab Med, SE-41345 Gothenburg, Sweden
关键词
HUMAN ARTICULAR CHONDROCYTES; ADULT STEM-CELLS; GENE-EXPRESSION; ENGINEERED CARTILAGE; BONE; PROLIFERATION; DEFECTS; GROWTH; KNEE; METALLOPROTEINASES;
D O I
10.1186/ar2800
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Autologous chondrocyte transplantation (ACT) is a routine technique to regenerate focal cartilage lesions. However, patients with osteoarthritis (OA) are lacking an appropriate long-lasting treatment alternative, partly since it is not known if chondrocytes from OA patients have the same chondrogenic differentiation potential as chondrocytes from donors not affected by OA. Methods Articular chondrocytes from patients with OA undergoing total knee replacement (Mankin Score > 3, Ahlback Score > 2) and from patients undergoing ACT, here referred to as normal donors (ND), were isolated applying protocols used for ACT. Their chondrogenic differentiation potential was evaluated both in high-density pellet and scaffold (Hyaff-11) cultures by histological proteoglycan assessment (Bern Score) and immunohistochemistry for collagen types I and II. Chondrocytes cultured in monolayer and scaffolds were subjected to gene expression profiling using genome-wide oligonucleotide microarrays. Expression data were verified by using real-time PCR. Results Chondrocytes from ND and OA donors demonstrated accumulation of comparable amounts of cartilage matrix components, including sulphated proteoglycans and collagen types I and II. The mRNA expression of cartilage markers (ACAN, COL2A1, COMP, CRTL1, SOX9) and genes involved in matrix synthesis (BGN, CILP2, COL9A2, COL11A1, TIMP4) was highly induced in 3D cultures of chondrocytes from both donor groups. Genes associated with hypertrophic or OA cartilage (ALPL, COL1A1, COL3A1, COL10A1, MMP13, POSTN, PTH1R, RUNX2) were not significantly regulated between the two groups of donors. The expression of 661 genes, including COMP, FN1, and SOX9, was differentially regulated between OA and ND chondrocytes cultured in monolayer. During scaffold culture, the differences diminished between the OA and ND chondrocytes, and only 184 genes were differentially regulated. Conclusions Only few genes were differentially expressed between OA and ND chondrocytes in Hyaff-11 culture. The risk of differentiation into hypertrophic cartilage does not seem to be increased for OA chondrocytes. Our findings suggest that the chondrogenic capacity is not significantly affected by OA, and OA chondrocytes fulfill the requirements for matrix-associated ACT.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Results 2 Years After Matrix-Associated Autologous Chondrocyte Transplantation Using the Novocart 3D Scaffold An Analysis of Clinical and Radiological Data
    Zak, Lukas
    Albrecht, Christian
    Wondrasch, Barbara
    Widhalm, Harald
    Vekszler, Gyoergy
    Trattnig, Siegfried
    Marlovits, Stefan
    Aldrian, Silke
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2014, 42 (07): : 1618 - 1627
  • [42] Arthroscopic matrix-associated, injectable autologous chondrocyte transplantation of the hip: significant improvement in patient-related outcome and good transplant quality in MRI assessment
    Henriette Bretschneider
    Siegfried Trattnig
    Stefan Landgraeber
    Albrecht Hartmann
    Klaus-Peter Günther
    Michael Dienst
    Jörg Schröder
    Stefan Fickert
    Knee Surgery, Sports Traumatology, Arthroscopy, 2020, 28 : 1317 - 1324
  • [43] Initial results of in vivo high-resolution morphological and biochemical cartilage imaging of patients after matrix-associated autologous chondrocyte transplantation (MACT) of the ankle
    Quirbach, Sebastian
    Trattnig, Siegfried
    Marlovits, Stefan
    Zimmermann, Valentin
    Domayer, Stephan
    Dorotka, Ronald
    Mamisch, Tallal C.
    Bohndorf, Klaus
    Welsch, Goetz H.
    SKELETAL RADIOLOGY, 2009, 38 (08) : 751 - 760
  • [44] The role of autologous bone grafting in matrix-associated autologous chondrocyte implantation at the knee: Results from the German Cartilage Registry (KnorpelRegister DGOU)
    Weishorn, Johannes
    Tischer, Thomas
    Niemeyer, Philipp
    Renkawitz, Tobias
    Bangert, Yannic
    KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2024, 32 (04) : 929 - 940
  • [45] Arthroscopic matrix-associated, injectable autologous chondrocyte transplantation of the hip: significant improvement in patient-related outcome and good transplant quality in MRI assessment
    Bretschneider, Henriette
    Trattnig, Siegfried
    Landgraeber, Stefan
    Hartmann, Albrecht
    Guenther, Klaus-Peter
    Dienst, Michael
    Schroeder, Joerg
    Fickert, Stefan
    KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2020, 28 (04) : 1317 - 1324
  • [46] Cartilage cell transplantation: Surgical technique with matrix-associated chondrocytes [Knorpelzelltransplantation: Operationstechnik mit matrixassoziierten chondrozyten]
    Schewe B.
    Fritz J.
    Gaissmaier C.
    Weise K.
    Der Unfallchirurg, 2006, 109 (7): : 577 - 582
  • [47] Short- to Midterm Clinical and Radiological Outcomes After Matrix-Associated Autologous Chondrocyte Implantation for Chondral Defects in Knees
    Dai, Xuesong
    Fang, Jinghua
    Wang, Siheng
    Luo, Jianyang
    Xiong, Yan
    Zhang, Miaofeng
    Zhu, Sunan
    Yu, Xinning
    ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE, 2021, 9 (02)
  • [48] Safety and efficacy of matrix-associated autologous chondrocyte implantation with spheroid technology is independent of spheroid dose after 4 years
    Niemeyer, Philipp
    Laute, Volker
    Zinser, Wolfgang
    John, Thilo
    Becher, Christoph
    Diehl, Peter
    Kolombe, Thomas
    Fay, Jakob
    Siebold, Rainer
    Fickert, Stefan
    KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2020, 28 (04) : 1130 - 1143
  • [49] Regenerative Potential of Platelet Concentrate Lysate in Mechanically Injured Cartilage and Matrix-Associated Chondrocyte Implantation In Vitro
    Weitkamp, Jan-Tobias
    Rolauffs, Bernd
    Feldheim, Moritz
    Bayer, Andreas
    Lippross, Sebastian
    Weuster, Matthias
    Smeets, Ralf
    Naujokat, Hendrik
    Grodzinsky, Alan Jay
    Kurz, Bodo
    Behrendt, Peter
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (24)
  • [50] Safety and efficacy of matrix-associated autologous chondrocyte implantation with spheroid technology is independent of spheroid dose after 4 years
    Philipp Niemeyer
    Volker Laute
    Wolfgang Zinser
    Thilo John
    Christoph Becher
    Peter Diehl
    Thomas Kolombe
    Jakob Fay
    Rainer Siebold
    Stefan Fickert
    Knee Surgery, Sports Traumatology, Arthroscopy, 2020, 28 : 1130 - 1143